BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11322883)

  • 1. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.
    Isenberg B; Thole H; Tümmler B; Demmer A
    Eur J Biochem; 2001 May; 268(9):2629-34. PubMed ID: 11322883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodomycin and iodipine, a structural analogue of azidopine, bind to a common domain in hamster P-glycoprotein.
    Demmer A; Andreae S; Thole H; Tümmler B
    Eur J Biochem; 1999 Sep; 264(3):800-5. PubMed ID: 10491126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the iodomycin binding site in hamster P-glycoprotein.
    Demmer A; Thole H; Kubesch P; Brandt T; Raida M; Fislage R; Tümmler B
    J Biol Chem; 1997 Aug; 272(33):20913-9. PubMed ID: 9252419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
    Greenberger LM
    J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane domain (TM) 9 represents a novel site in P-glycoprotein that affects drug resistance and cooperates with TM6 to mediate [125I]iodoarylazidoprazosin labeling.
    Song J; Melera PW
    Mol Pharmacol; 2001 Aug; 60(2):254-61. PubMed ID: 11455011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.
    Greenberger LM; Lisanti CJ; Silva JT; Horwitz SB
    J Biol Chem; 1991 Nov; 266(31):20744-51. PubMed ID: 1682313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1.
    Zhang X; Collins KI; Greenberger LM
    J Biol Chem; 1995 Mar; 270(10):5441-8. PubMed ID: 7890659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine 268 adjacent to transmembrane helix 5 of hamster P-glycoprotein is the major photobinding site of iodomycin in CHO B30 cells.
    Demmer A; Thole H; Raida M; Tümmler B
    FEBS Open Bio; 2021 Apr; 11(4):1084-1092. PubMed ID: 33565718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.
    Dey S; Ramachandra M; Pastan I; Gottesman MM; Ambudkar SV
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10594-9. PubMed ID: 9380680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
    Beaudet L; Urbatsch IL; Gros P
    Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
    Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
    Morris DI; Greenberger LM; Bruggemann EP; Cardarelli C; Gottesman MM; Pastan I; Seamon KB
    Mol Pharmacol; 1994 Aug; 46(2):329-37. PubMed ID: 7915819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the cyclosporin-binding site in P-glycoprotein.
    Demeule M; Laplante A; Murphy GF; Wenger RM; Béliveau R
    Biochemistry; 1998 Dec; 37(51):18110-8. PubMed ID: 9922180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
    Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M
    Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein.
    Wu Q; Bounaud PY; Kuduk SD; Yang CP; Ojima I; Horwitz SB; Orr GA
    Biochemistry; 1998 Aug; 37(32):11272-9. PubMed ID: 9698374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites.
    Daoud R; Desneves J; Deady LW; Tilley L; Scheper RJ; Gros P; Georges E
    Biochemistry; 2000 May; 39(20):6094-102. PubMed ID: 10821682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
    Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
    Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
    Greenberger LM; Yang CP; Gindin E; Horwitz SB
    J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.
    Shapiro AB; Fox K; Lam P; Ling V
    Eur J Biochem; 1999 Feb; 259(3):841-50. PubMed ID: 10092872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.